Literature DB >> 18328261

Differential effects of prion particle size on infectivity in vivo and in vitro.

Petra Weber1, Lukas Reznicek, Gerda Mitteregger, Hans Kretzschmar, Armin Giese.   

Abstract

The conversion of cellular prion protein to the disease-associated isoform (PrP(Sc)) has been suggested to follow a mechanism of seeded aggregation. Here, we show that fragmentation of PrP(Sc) aggregates by sonication increases converting activity in cell culture in a way similar to in vitro conversion assays. In contrast, under the same conditions the infectious titer of sonicated samples in vivo was reduced. We modified the size distribution of PrP(Sc) by adsorption to nitrocellulose, which resulted in a reduction of the infectious titer in non-sonicated samples and an increase in sonicated samples. Our results indicate that NC-adsorption can (i) block some active sites of PrP(Sc) aggregates and (ii) reduce the rate of clearance from the brain. For large particles with low clearance the effect of NC-particles on the number of available active sites may dominate, whereas for smaller particles (i.e. sonicated samples) the effect of NC-adsorption on clearance dominates resulting in increased infectivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18328261     DOI: 10.1016/j.bbrc.2008.02.115

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Lower specific infectivity of protease-resistant prion protein generated in cell-free reactions.

Authors:  Mikael Klingeborn; Brent Race; Kimberly D Meade-White; Bruce Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

2.  A specific population of abnormal prion protein aggregates is preferentially taken up by cells and disaggregated in a strain-dependent manner.

Authors:  Young Pyo Choi; Suzette A Priola
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

3.  Analyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prions.

Authors:  Daniela Saverioni; Silvio Notari; Sabina Capellari; Ilaria Poggiolini; Armin Giese; Hans A Kretzschmar; Piero Parchi
Journal:  J Biol Chem       Date:  2013-07-29       Impact factor: 5.157

4.  Prion subcellular fractionation reveals infectivity spectrum, with a high titre-low PrPres level disparity.

Authors:  Victoria Lewis; Cathryn L Haigh; Colin L Masters; Andrew F Hill; Victoria A Lawson; Steven J Collins
Journal:  Mol Neurodegener       Date:  2012-04-26       Impact factor: 14.195

5.  PK-sensitive PrP is infectious and shares basic structural features with PK-resistant PrP.

Authors:  Gustavo Sajnani; Christopher J Silva; Adriana Ramos; Miguel A Pastrana; Bruce C Onisko; Melissa L Erickson; Elizabeth M Antaki; Irina Dynin; Ester Vázquez-Fernández; Christina J Sigurdson; J Mark Carter; Jesús R Requena
Journal:  PLoS Pathog       Date:  2012-03-01       Impact factor: 6.823

6.  Establishing quantitative real-time quaking-induced conversion (qRT-QuIC) for highly sensitive detection and quantification of PrPSc in prion-infected tissues.

Authors:  Song Shi; Gerda Mitteregger-Kretzschmar; Armin Giese; Hans A Kretzschmar
Journal:  Acta Neuropathol Commun       Date:  2013-08-02       Impact factor: 7.801

7.  Highly infectious CJD particles lack prion protein but contain many viral-linked peptides by LC-MS/MS.

Authors:  Terry Kipkorir; Sarah Tittman; Sotirios Botsios; Laura Manuelidis
Journal:  J Cell Biochem       Date:  2014-11       Impact factor: 4.429

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.